Skip to main content
. Author manuscript; available in PMC: 2015 Jan 28.
Published in final edited form as: Br J Haematol. 2011 Aug 25;155(2):150–166. doi: 10.1111/j.1365-2141.2011.08852.x

Figure 2.

Figure 2

Model for immunoediting in relation to MF/SS stage. The progression of MF/SS is illustrated as impacted by the level of tumour immunity present and underlying genetic alterations that contribute to tumour sculpting to stimulate progression to more advance stages of the disease.